Liver Failure: Clinical Trials

68 trials for Liver Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 15 unknown, 11 recruiting, 6 withdrawn. 68 Phase 1, 39 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 168Completed 26, Unknown 15, Recruiting 11, Withdrawn 6, Active not recruiting 4, Not yet recruiting 4, Suspended 1, Terminated 1
Phase 239Completed 13, Unknown 12, Recruiting 6, Withdrawn 3, Active not recruiting 2, Not yet recruiting 2, Terminated 1

Follow Liver Failure: new trials by email Literature Review of Liver Failure trials Research Report on Liver Failure

Trials (filtered) newest first · largest first

All 68 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RENEW: Study of Porcine Liver Support in Participants With Acute-on-Chronic Liver Failure
metra® Extracorporeal Liver Cross-Circulation (ELC) system (OrganOx), EGEN-5784 (genetically engineered porcine liver) - Acute on Chronic Liver Failure (ACLF), Hepatic Encephalopathy (HE)
Phase 1 / Phase 2Not yet recruitingeGenesis, INC202026-10-012026-09-21
TLI- and ATG-Enabled Minimization Protocol in Liver Transplantation
Anti-Thymocyte Globulin, ATG (Rabbit), Total lymphoid irradiation - Liver Failure
Phase 1 / Phase 2RecruitingStanford University122026-09-012026-10-07
Evaluation of the Outcome of Fecal Microbiota Transplantation
Fecal Microbiota Transplantation, FMT Matched Placebo, Rifaximin、Lactulose - Hepatic Encephalopathy, Fecal Microbiota Transplantation
Phase 1 / Phase 2Not yet recruitingAir Force Military Medical University, China402026-03-072026-03-06
Immune Tolerance Induction After Liver Transplantation
Donor Hematopoietic Stem and Progenitor Cell Infusion - Liver Transplantation, Immune Tolerance
Phase 1 / Phase 2RecruitingUniversity of California, Los Angeles122026-02-202026-03-12
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)
umbilical cord Mesenchymal Stem Cell - Acute-On-Chronic Liver Failure
Phase 1Not yet recruitingInstitute of Liver and Biliary Sciences, India102026-01-012025-08-28
Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome
Chemically induced pluripotent stem cells biological Artificial Liver - Liver Failure, Small-for-Size Syndrome
Phase 1 / Phase 2RecruitingBeijing Friendship Hospital122025-12-012026-04-20
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
Single Dose G1090N, Multiple dosing of G1090N - Acute-on-Chronic Liver Failure
Phase 1CompletedGenfit522025-08-262026-01-16
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
Commensal Bacteria Strains - Liver Diseases, Liver Failure
Phase 1RecruitingUniversity of Chicago242025-08-042025-11-04
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver - Liver Diseases, Liver Cancer
Phase 1 / Phase 2RecruitingAMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC902025-06-012025-07-08
Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure
Combining the QH-1A bioartificial liver device with mesenchymal stem cells for blood purification(4 hours), Combining the QH-1A bioartificial liver device with mesenchymal stem cells for blood purification(6 hours), Combining the QH-1A bioartificial liver device with mesenchymal stem cells for blood purification(8 hours) - Acute-On-Chronic Liver Failure
Phase 1Active not recruitingThird Affiliated Hospital, Sun Yat-Sen University152025-05-072025-05-30
MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation
MSC-EVs - Liver Failure, Mesenchymal Stem Cell
Phase 1Not yet recruitingThird Affiliated Hospital, Sun Yat-Sen University302025-04-012025-02-13
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
RTX001 - End-stage Liver Disease (ESLD), Cirrhosis, Liver
Phase 1 / Phase 2Active not recruitingResolution Therapeutics Limited302024-10-152026-10-05
miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial
miroliverELAP treatment - Acute Liver Failure, Acute Liver Injury, Drug Induced
Phase 1CompletedMiromatrix Medical Inc.102024-10-052026-03-06
A Study of SIPLIZUMAB in AILD and LT Patients
Siplizumab - Autoimmune Liver Disease, Liver Transplant Disorder
Phase 1RecruitingElizabeth C. Verna82024-09-112025-11-24
Safety and Effectiveness of Mesenchymal Stem Cells in Blood Purification for the Treatment of Liver Failure
It is loaded with a mesenchymal stem cells reaction device for blood purification - Liver Failure
Phase 1RecruitingKebo Zhong102024-04-232026-04-15
Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults
a single course of micro-encapsulated hepatocytes intraperitoneal transplantation therapy - Acute-On-Chronic Liver Failure, Chronic Liver Failure
Phase 1RecruitingRenJi Hospital102024-03-012025-06-27
MSC-EV in Acute-on-Chronic Liver Failure After Liver Transplantation
MSC-EV - Liver Failure, Acute on Chronic
Phase 1WithdrawnThird Affiliated Hospital, Sun Yat-Sen University2023-09-302023-10-12
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
standard medical treatment, Placebo, hUC-MSC - Acute-On-Chronic Liver Failure
Phase 1 / Phase 2RecruitingBeijing 302 Hospital1502023-09-302024-05-07
The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure
HepaCure, DPMAS and LPE - Acute on Chronic Hepatic Failure, Liver Failure
Phase 1 / Phase 2RecruitingHexaell Biotech Co., Ltd.922023-09-222025-02-25
The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver Failure
MSC-EVs - Acute-On-Chronic Liver Failure, Acute Liver Failure
Phase 1 / Phase 2WithdrawnThird Affiliated Hospital, Sun Yat-Sen University2023-09-012023-10-12

Showing 20 of 68. Sign in to see all of them.

Narrower conditions

Acute-On-Chronic Liver Failure (17)  ·  End Stage Liver Disease (16)  ·  Hepatic Encephalopathy (16)  ·  Fibrosis (9)  ·  Liver Cirrhosis (9)  ·  Liver Diseases (7)  ·  Liver Failure, Acute (7)  ·  Renal Insufficiency (3)  ·  Hepatic Insufficiency (2)  ·  Hepatitis B (2)  ·  Neoplasm Metastasis (2)  ·  Acute Kidney Injury (1)  ·  Brain Diseases (1)  ·  Brain Edema (1)

Broader conditions

Digestive System Diseases (68)  ·  Hepatic Insufficiency (66)  ·  Liver Diseases (61)  ·  Pathological Conditions, Signs and Symptoms (21)  ·  Pathologic Processes (20)  ·  Central Nervous System Diseases (17)  ·  Nervous System Diseases (17)  ·  Nutritional and Metabolic Diseases (17)  ·  Brain Diseases (16)  ·  Brain Diseases, Metabolic (16)  ·  Metabolic Diseases (16)  ·  Liver Failure, Acute (14)  ·  Fibrosis (7)  ·  Urogenital Diseases (6)

Interventions

Congresses as Topic (3)  ·  Fecal Microbiota Transplantation (3)  ·  Lactulose (2)  ·  Amino Acids (1)  ·  Amino Acids, Branched-Chain (1)  ·  Antilymphocyte Serum (1)  ·  Antiviral Agents (1)  ·  Carboplatin (1)  ·  Drug Delivery Systems (1)  ·  Filgrastim (1)  ·  Flumazenil (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  NOS2 protein, human (1)  ·  Paclitaxel (1)  ·  Peripheral Blood Stem Cell Transplantation (1)

Sponsors

Third Affiliated Hospital, Sun Yat-Sen University (6)  ·  Air Force Military Medical University, China (4)  ·  University of Alberta (4)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (3)  ·  Virginia Commonwealth University (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Beijing 302 Hospital (2)  ·  AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC (1)  ·  ANRS, Emerging Infectious Diseases (1)  ·  Amgen (1)  ·  Beijing Friendship Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  Duke University (1)  ·  Elizabeth C. Verna (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)

Countries

United States (23)  ·  China (19)  ·  Canada (5)  ·  France (5)  ·  Spain (4)  ·  Belgium (3)  ·  India (3)  ·  United Kingdom (3)  ·  Germany (2)  ·  Italy (2)  ·  Austria (1)  ·  Hungary (1)  ·  Iran (1)  ·  Japan (1)  ·  Poland (1)

Top investigators

Daiming Fan (3)  ·  Yang Yang, PHD, MD (2)  ·  Anil Dhawan, Professor (1)  ·  Baburao Koneru, MD (1)  ·  Charles Gorodetzky, MD, PhD (1)  ·  Cray V. Noah, MD (1)  ·  David R Grant, MD (1)  ·  Deborah Haller (1)  ·  Dina Kao, MD (1)  ·  Dr. Shiv Kumar Sarin, DM (1)

Results publications

PMID 17903050, PMID 19455046, PMID 20512995, PMID 25715177, PMID 28284916, PMID 30568347, PMID 30863450, PMID 31038755, PMID 31751317, PMID 33011075, PMID 35313729, PMID 35728046, PMID 37975059, PMID 38109364, PMID 38153225, PMID 38925694, PMID 40233953, PMID 41503571, PMID 6749458, PMID 818729

NIH funding

2009 (1), 2017 (1), 2019 (1), N01CM00100 (1), P30CA047904 (1), P30DK034989 (1), R21TR002024 (1), U01AT004428 (1), U01CA062490 (1), U01CA062502 (1), U01CA062505 (1), U01CA069856 (1), U01CA070095 (1), U01CA099168 (1), UM1CA186690 (1)